EVALUATION OF COMBINATION OF BIPHASIC CALCIUM PHOSPHATE AND PLATELET-RICH FIBRIN AS GRAFTING MATERIAL FOR SINUS LIFT AUGMENTATION | ||||
| Alexandria Dental Journal | ||||
| Article 2, Volume 40, Issue 2, December 2015, Page 140-147 PDF (1.06 MB) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/adjalexu.2015.59131 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Khalfalla Aimen E* ; Fahmy Magued H.* ; Ashwah Adham A* | ||||
| B.D.S. Faculty of Dentistry, Tripoli University. | ||||
| Abstract | ||||
| Introduction: The performance of implant surgery in the posterior maxilla often poses challenges due to insufficient available bone. Sinus floor elevation is developed to increase needed vertical height to overcome this problem. Many grafting materials had been used to augment subsinus area. Recently, several authors have shown that simultaneous sinus lift and implantation using autologous platelet-rich fibrin combined with biphasic calcium phosphate as a grafting material is a reliable procedure promoting bone augmentation in the maxillary sinus. Objectives: This study was aiming to evaluate bone formation after maxillary sinus membrane elevation using lateral window technique and simultaneous implant placement using biphasic calcium phosphate combined with platelet rich fibrinas agrafting material. Materials and methods: The present study was conducted on ten patients with age ranged from 30-50 years seeking implantation of their lost posterior maxillary teeth, and had limited bone height below the floor of the maxillary sinus, secondary to sinus pneumatization. Patients were selected on the basis of history, clinical examination and radiographic examination using panoramic radiography and cone-beam CT. Conclusion: Platelet-rich fibrin in addition to biphasic calcium phosphate may favor the formation of new bone after maxillary sinus augmentation. The effectiveness of PRF depends not only on its features but also the properties of co-administered grafting material. | ||||
| Keywords | ||||
| dental implant; Biphasic Calcium phosphate; Platelet-rich Fibrin; Sinus-lift | ||||
| References | ||||
|
1. Raja SV. Management of the posterior maxilla with sinus Lift: Review of Techniques. J Oral MaxillofacSurg 2009; 67: 1730.
2. Diaz-Romeral-Bautista M, Manchon-Miralles A, Asenjo-Cabezon J, Cebrian-Carretero JL, TorresGarcia-DencheJ, Linares-Garcia-Valdecasas R. Autogenous calvarium bone grafting as a treatment for severe bone resorption in the upper maxilla: a case report. Med Oral Patol Oral Cir Bucal 2010; 15:e361-5.
3. Hieu PD, Chung JH, Yim SB, Hong KS. A radiographical study on the changes in height of grafting materials after sinus lift: a comparison between two types of xenogenic materials. J Periodontol Implant Sci 2010; 40: 25-32.
4. Browaeys H, BouvryP , De Bruyn H. A literature review on biomaterial in sinus augmentation procedures. Clin implant Dent Relat Res 2007;9:166- 177.
5. Boyne PJ, James RA. Grafting of the maxillary sinus floor with autogenous marrow and bone. J Oral Surg 1980; 38: 613-6.
6. Klijn RJ, Meijer GJ, Bronkhorst EM, Jansen JA. A meta-analysis of histomorphometric results and graft healing time of various biomaterials compared to autologous bone used as sinus floor augmentation material in humans. Tissue Eng Part B Rev 2010;16:493-507.
7. Klijn RJ, Meijer GJ, Bronkhorst EM, Jansen JA. Sinus floor augmentation surgery using autologous bone grafts from various donor sites: a meta-analysis of the total bone volume. Tissue Eng Part B Rev 2010;16:295-303.
8. Schlegel KA, Schultze-Mosgau S, Wiltfang J, Neukam FW, Rupprecht S, Thorwarth M. Changes of mineralization of free autogenous bone grafts used for sinus floor elevation. Clin Oral Implants Res 2006;17:673-8.
9. Choukroun J, Adda F, Schoeffler C. An opportunity in perioimplantology: The PRF. Implantodontie 2001;42:55-62.
10. Dohan Ehrenfest D.M., Rasmusson L., Albrektsson T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and plateletrich fibrin (L-PRF). Trends Biotechnol2009;27:158-67.
11. Dohan DM, Choukroun J, Diss A. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101: 51-5.
12. Dohan DM, Choukroun J, Diss A. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101: 45-50.
13. Dohan Ehrenfest DM, Del Corso M, Diss A. Threedimensional architecture and cell composition of a Choukroun's platelet-rich fibrin clot and membrane. J Periodontol 2010;81:546-55.
14. Dohan Ehrenfest DM, Bielecki T, Jimbo R. Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF). Curr Pharm Biotechnol 2012;13:1145- 52.
15. Dohan Ehrenfest DM, de Peppo GM, Doglioli P. Slow release of growth factors and thrombospondin-1 in Choukroun's platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies. Growth Factors 2009;27:63-9.
16. Zumstein MA, Berger S, Schober M. Leukocyte- and platelet-rich fibrin (L-PRF) for long-term delivery of growth factor in rotator cuff repair: review, preliminary results and future directions. Curr Pharm Biotechnol 2012;13:1196-206.
17. Ozdemir H, Ezirganli S, Isa Kara M. Effects of platelet rich fibrin alone used with rigid titanium barrier. Arch Oral Biol 2013;58:537-44.
18. Bajaj P, Pradeep AR, Agarwal E, Rao NS, Naik SB, Priyanka N, et al. Comparative evaluation of autologous platelet-rich fibrin and platelet-rich plasma in the treatment of three-wall intrabony defects in chronic periodontitis: a randomized controlled clinical trial. J Periodontol 2013; 8: 573-81.
19. Nieminen T, Rantala I, Hiidenheimo I. Degradative and mechanical properties of a novel resorbable plating system during a 3-year follow-up in vivo and in vitro. J Mater Sci Mater Med 2008;19:1155-63.
20. Albrektsson T, Johansson C. Osteoinduction, osteoconduction and osseointegration. Eur Spine J 2001;10: 96-101.
21. Constantz BR, Barr BM, Ison IC. Histological, chemical, and crystallographic analysis of four calcium phosphate cements in different rabbit osseous sites. J Biomed Mater Res 1998;43:451-61.
22. Almasri M, Altalibi M. Efficacy of reconstruction of alveolar bone using an alloplastic hydroxyapatite tricalcium phosphate graft under biodegradable chambers. Br J Oral Maxillofac Surg 2011;49:469-73.
23. Reinert S, König S, Bremerich A, Eufinger H, Krimmel M. Stability of bone grafting and placement of implants in the severely atrophic maxilla. Br J Oral Maxillofac Surg 2003; 41: 249-55.
24. Scarano A, Degidi M, Iezzi G, Pecora G, Piattelli M, Orsini G, et al. Maxillary sinus augmentation with different bio- materials: a comparative histologic and histomor- phometric study in man. Implant Dent 2006; 15: 197-207
25. Sakka S, Coulthard P. Bone quality: a reality for the process of osseointegration. Implant Dent 2009; 18:480-5.
26. Felice P, Pistilli R, Piattelli M, Soardi E, Barausse C, Esposito M. 1-stage versus 2 stage lateral sinus lift procedures: 1-year post-loading results of a multicenter randomised controlled trial. Eur J Oral Implantol2014;7:65-75.
27. Pariente L, Dada K, Daas M. Mini-lateral windows for minimally invasive maxillary sinus augmentation: case series of a new technique. Implant Dent 2014;23: 371- 7.
28. Galindo-moreno P, Moreno-riestra I, Avila G, Fernández-barbero JE, Mesa F, Aguilar M, et al. Histomorphometric comparison of maxillar y pristine bone and composite bone graft biopsies obtained after sinus augmentation. Clin Oral Implants Res 2010; 21: 122-8.
29. Scarano A, Degidi M, Iezzi G, Pecora G, Piattelli M, Orsini G, et al. Maxillary sinus augmentation with different bio- materials: a comparative histologic and histomorphometric study in man. Implant Dent 2006; 15:197-207.
30. Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J et al. Platelet-rich fibrin (PRF): a second generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:e45-50.
31. Pereira CC, Gealh WC, Meorin-Nogueira L, GarciaJúnior IR, Okamoto R. Piezosurgery applied to implant dentistry: clinical and biological aspects. J Oral Implantol 2014;40:401-8.
32. Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, et al. Platelet-rich fibrin (PRF): a second generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrate?. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 101: 51-5.
33. He L, Lin Y, Hu X, Zhang Y, Wu H. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:707-13.
34. Simonpieri A, Choukroun J, Del Corso M, SammartinoG, DohanEhrenfest DM. Simultaneous sinus-lift and implantation using microthreaded implants and leukocyte- and platelet-rich fibrin as sole grafting material: a six-year experience. Implant Dent 2011;20:2-12.
35. Mazor Z, Horowitz RA, Del Corso M, Prasad HS, Rohrer MD, Dohan Ehrenfest DM. Sinus floor augmentation with simultaneous implant placement using Choukroun's platelet-rich fibrin as the sole grafting material: a radiologic and histologic study at 6 months. J Periodontol 2009;80:2056-64.
36. Kim BJ, Lee JH. The retrospective study of survival rate of implants with maxillary sinus floor elevation. J Korean Assoc Oral Maxillofac Surg 2010;36:108-18. | ||||
|
Statistics Article View: 132 PDF Download: 436 |
||||
